Applied Biosystems - 32 News

Life Technologies to Sell Mass Spectrometry Business to Danaher for $450 Million in Cash

07-Sep-2009 - Life Technologies Corporation announced it has signed a definitive agreement to sell its ownership stake in its mass spectrometry business, operated as a joint venture, to Danaher Corporation for $450 million in cash. Danaher has also signed an agreement to acquire Life Technologies’ joint ...

QIAGEN and Applied Biosystems Settle all Disputes over Real-Time PCR Thermal Cycler Patents

26-Jan-2009 - Corbett, QIAGEN, ltf Labortechnik GmbH & Co. KG, and Applied Biosystems, LLC, part of Life Technologies Corporation announced a settlement of their disputes concerning infringement by Corbett’s Rotor-Gene_TM Real-Time PCR-Cyclers and Applied Biosystems’ Real-Time Thermal Cycler Instrument ...

Invitrogen and Applied Biosystems Complete Merger

Combined Company, Called Life Technologies Corporation, is a Global Leader in Biotechnology Reagents and Systems

25-Nov-2008 - Invitrogen Corporation and Applied Biosystems Inc. announced the successful completion of their merger transaction. The new company will be named Life Technologies Corporation and is traded on the NASDAQ Global Select Market under the ticker symbol "LIFE" beginning November 24, 2008. “This is ...

Applied Biosystems and Asuragen collaborate with the Critical Path Institute to improve drug toxicity screening

10-Nov-2008 - Drug toxicity is a leading cause of pre-clinical drug failures. The US Food and Drug Administration (FDA) and other regulatory organisations have called upon the pharmaceutical industry to develop more effective tools to help avoid these costly failures, reduce the number of failed compounds, and ...

Enigma Diagnostics Announces Patent Licence With Applied Biosystems

27-Oct-2008 - Enigma Diagnostics Limited announced that it has signed a third licence agreement with Applied Biosystems. The licence provides Enigma with access to claims of US Patent No. 5,928,907 that describe methods for monitoring nucleic acid amplification in real-time. This is the first such licence ...

Heart disease specialists meet Spanish footballers to develop tools for detecting sudden death syndrome

Applied Biosystems hosts first symposium on sudden death in football players and other European athletes

17-Jul-2008 - Leading cardiovascular research scientists and a number of prominent football figures from Spain recently convened at the world's first symposium focused on the molecular analysis of sudden death in football players. The I Symposium de Prevención en el Futbol was held at the Hospital Clínico San ...

Applied Biosystems, 454 Life Sciences and Illumina Join 1000 Genomes Project

Biotech Innovators Will Contribute to International Effort To Produce Most Detailed Map of Genetic Variation

13-Jun-2008 - Leaders of the 1000 Genomes Project announced that three firms that have pioneered development of new sequencing technologies have joined the international effort to build the most detailed map to date of human genetic variation as a tool for medical research. The new participants are: Applied ...

Scientists in Spain develop new methods for monitoring drug abuse by analysing wastewater

20-May-2008 - Scientists at the Spanish Council for Scientific Research (CSIC) in Barcelona have developed a new method for monitoring the consumption of drugs of abuse in the general population. This method, which was developed using analytical laboratory technology from Applied Biosystems/MDS Analytical ...

Scientists in Spain Develop a Panel of Genetic Markers for Tracing Meat from Farm to Fork

Researchers collaborate with Applied Biosystems to validate specific genetic polymorphisms for identifying individual pigs from commercial breeds

11-Dec-2007 - Scientists at the Universitat Autònoma de Barcelona, Spain, have developed and validated an identity test that can be used to confirm the breed and origin of meat from farm animals. The test was developed in collaboration with Applied Biosystems , an Applera Corporation business, and uses a ...

Scientists Discover New Molecular Markers for Testicular Cancer

Researchers in the Netherlands use new technology from Applied Biosystems to identify different expression patterns of microRNA molecules in normal and cancerous cells

18-Oct-2007 - Scientists at the Erasmus MC-University Medical Center in Rotterdam, The Netherlands and Applied Biosystems, an Applera Corporation business, have made significant advances in testicular cancer research by identifying and analyzing a set of specific microRNA molecular markers that are involved in ...